Continue Reading Below
Commercial waste removal specialist Stericycle (NASDAQ: SRCL) saw its stock surge 12% in early Thursday trading, before settling down to a more modest 8% move by 12 p.m. EST.
As you've probably guessed, earnings had something to do with the move. Stericycle reported its fiscal Q4 and full-year earnings last night, and the numbers exceeded analyst expectations. For the fourth quarter, the company reported 2% revenue growth to $906 million (analysts had expected less than $904 million). The company earned only $0.14 per share on that revenue, but said its "non-GAAP earnings" were a full $1 per share, which exceeded analyst projectionsfor a $0.93 profit.
For the year, Stericycle reported GAAP earnings of $2.08 per share (down 30% year over year) on sales of $3.56 billion (up 19%).
Companies hire Stericycle to make their hazmat waste go away. Image source: Getty Images.
Continue Reading Below
Management offered up no projections for how it expects to perform in 2017 to guide investors' decision on what to do next, so let me give my take instead. Based on reported earnings, Stericycle stock now costs more than 40 times earnings. That's about 33% more expensive than the stock looked heading into earnings yesterday.
On the other hand, free cash flow last year was simply brilliant, with Stericycle reporting cash profits generated of $411.2 million -- nearly twice recorded profits and a 49% improvement over last year's cash haul.
On the third hand, though, Stericycle stock now carries an enterprise value of $10.1 billion, resulting in an enterprise-value-to-free-cash-flow ratio of just 24.5 on the stock. So arguably, viewed from the perspective of EV/FCF, Stericycle stock is not just cheaper than it looks when valued on P/E, but also cheaper than it looked just 24 hours ago. Whether it's cheap enough to buy given analyst predictionsthat long-term growth will average only 10%, though, is another question. Personally, despite last night's great results, I vote "no."
10 stocks we like better than Stericycle
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Stericycle wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of February 6, 2017